In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque sits down with Luis Valente, CEO and Co-Founder of iLoF, a digital health company pioneering a breakthrough AI platform to accelerate the future of personalized drug discovery and development.

The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF

Oncology Data Advisor®